CBD Science
The endocannabinoid system is one of the most important concepts for understanding CBD. Often mentioned in articles about cannabidiol, it remains poorly explained to the general public. Much of the content presents it as a simple “wellness system,” when in fact it is a complex biological network involved in numerous physiological functions. Understanding this system allows for a better distinction between CBD and THC, helps avoid exaggerated claims, and places cannabidiol within a rigorous scientific framework.
The endocannabinoid system, often abbreviated as ECS, is composed of molecules naturally produced by the body, receptors, and enzymes. It plays a role in internal regulatory mechanisms, particularly those affecting the nervous system, immunity, mood, pain, appetite, sleep, and overall bodily balance. It is not a system "created for cannabis," but a natural biological system discovered primarily through cannabinoid research.
This article explains how the endocannabinoid system works, its connection to plant cannabinoids like CBD and THC, its main receptors, its scientific limitations, and the necessary precautions when discussing cannabidiol. This is informational, non-medical content intended to improve understanding of CBD without encouraging consumption or making any therapeutic claims.
What is the endocannabinoid system?
The endocannabinoid system is a biological communication system present in humans and other mammals. It plays a role in the body's internal balance, also known as homeostasis. Homeostasis refers to the body's ability to maintain a certain equilibrium despite internal or external variations such as stress, fatigue, inflammation, diet, temperature, pain, sleep-wake cycles, or environmental changes.
The endocannabinoid system functions thanks to three main components: molecules naturally produced by the body, called endocannabinoids; receptors on which these molecules can act; and enzymes responsible for producing or breaking down these molecules at the right time. A scientific review published on PubMed summarizes this system as a set composed of endocannabinoids, cannabinoid receptors, and enzymes involved in their synthesis and breakdown.
See the PubMed scientific review on the endocannabinoid system.
It is important to emphasize that this system exists independently of hemp or cannabis consumption. The human body produces its own endocannabinoid molecules. Plant cannabinoids, called phytocannabinoids, can interact with certain elements of this system, but they are not the cause of its existence.
To better understand CBD as a molecule, you can read the previous article:
CBD: scientific definition of cannabidiol.
Why do we talk about the “endocannabinoid” system?
The term “endocannabinoid” may sound strange. It comes from the fact that this system was identified in part through research on the effects of cannabinoids found in cannabis, particularly THC. Scientists initially studied molecules produced by the plant, then discovered that the body possesses its own receptors and produces its own molecules capable of interacting with these receptors.
The prefix “endo” means “inside.” Endocannabinoids are therefore cannabinoids produced within the body. They do not originate from the plant. They act as chemical messengers and are involved in subtle biological signals, often produced locally and rapidly broken down after their action.
This discovery has changed our understanding of the effects of cannabinoids. It has shown that the interactions between cannabis, hemp, CBD, THC, and the human body are not a simple reaction. The endocannabinoid system is a vast, dynamic network that is still being studied.
To further understand the distinction between the plant and its molecules, see:
Hemp, cannabis, CBD and THC: understanding the differences.
The three main components of the endocannabinoid system
To understand the endocannabinoid system, three major components must be considered: endocannabinoids, cannabinoid receptors, and enzymes. These elements work together to transmit, modulate, and then block certain biological signals.
1. Endocannabinoids
Endocannabinoids are molecules naturally produced by the body. The two most commonly cited are anandamide and 2-AG. They are produced on demand, when the body needs them, and then rapidly broken down by specific enzymes. Unlike some hormones that are stored in advance, endocannabinoids are often produced locally, in response to a specific signal.
2. Cannabinoid receptors
Cannabinoid receptors are structures located on the surface of certain cells. They receive chemical signals and trigger biological responses. The two best-known receptors are CB1 and CB2. The CB1 receptor is particularly prevalent in the central nervous system, while CB2 is more associated with the immune system and certain peripheral tissues.
3. Enzymes
Enzymes control the duration and intensity of the signal. They participate in the production and breakdown of endocannabinoids. Without these enzymes, the signals would last too long or would not be properly regulated. This ability to act quickly and then stop is what makes the endocannabinoid system such a finely tuned regulatory system.
CB1 and CB2 receptors: differences and roles
CB1 and CB2 receptors are the two most studied cannabinoid receptors. They are not distributed in the same way throughout the body and do not have exactly the same functions. Their distribution partly explains why THC, which acts strongly on CB1, produces very different effects from CBD.
The CB1 receiver
The CB1 receptor is primarily found in the central nervous system. It is located in specific brain regions involved in memory, coordination, perception, pain, appetite, and mood. THC can bind to and activate this receptor, which explains its psychoactive effects.
CBD, on the other hand, does not behave like THC on CB1. This difference is crucial. It explains why CBD does not produce the "high" associated with THC-rich cannabis.
The CB2 receiver
The CB2 receptor is more closely associated with the immune system and certain peripheral tissues. It is frequently studied in the context of the inflammatory response and immune regulation. This does not mean that a CBD product can claim a medical effect on inflammation, but it explains why the endocannabinoid system is of such interest to biomedical research.
INSERM emphasizes that CBD does not bind to the same receptors as THC in the endocannabinoid system, which highlights the need to clearly distinguish between the two molecules in educational materials.
Read the INSERM article on CBD and health.
Endocannabinoids: anandamide and 2-AG
Endocannabinoids are the natural messengers of the endocannabinoid system. The two best known are anandamide and 2-arachidonoylglycerol, often abbreviated 2-AG. These molecules are produced by the body and participate in the transmission of signals between cells.
Anandamide
Anandamide is sometimes called the “happiness molecule” in some mainstream media. This expression is a gross oversimplification and should be used with caution. Scientifically, anandamide is an endocannabinoid involved in signaling mechanisms. It can bind to cannabinoid receptors and is rapidly broken down by an enzyme called FAAH.
Some studies are exploring how CBD might indirectly influence anandamide levels, particularly through the inhibition of certain degradation mechanisms. However, these mechanisms remain complex and should not be interpreted as guarantees of a specific effect.
The 2-AG
2-AG is another major endocannabinoid. It is present in significant quantities in the body and is involved in several signaling processes. Like anandamide, it is produced on demand and then broken down by enzymes. Its exact role depends on the tissue, the biological context, and the type of receptors involved.
These two molecules demonstrate that the endocannabinoid system is primarily an internal system within the human body. Plant cannabinoids like CBD and THC interact with an existing network, but do not replace it.
Enzymes of the endocannabinoid system: production, regulation, degradation
Enzymes are essential for the proper functioning of the endocannabinoid system. They enable the body to produce endocannabinoids when needed and then break them down once they have served their purpose. This control prevents excessive or prolonged stimulation of the receptors.
Among the enzymes frequently cited are FAAH, associated with the degradation of anandamide, and MAGL, associated with the degradation of 2-AG. These enzymes are of scientific interest because they can influence the duration and intensity of endocannabinoid signals.
This enzymatic dimension is important for understanding why CBD is sometimes described as an indirect molecule. Rather than strongly activating a receptor like THC, CBD may influence certain signaling, degradation, or modulation mechanisms. But here again, caution is necessary: the mechanisms observed in the laboratory do not always translate directly into predictable effects in all users.
What is the biological role of the endocannabinoid system?
The endocannabinoid system is involved in several biological functions. It does not control a single function, but participates in regulatory mechanisms. Its role can vary depending on the tissues, receptors, molecules involved, and physiological context.
Mood and stress regulation
The endocannabinoid system is being studied for its role in certain stress responses and mood regulation. This explains why many articles associate CBD with relaxation. However, scientific interest should not be confused with proven efficacy. Anxiety disorders, chronic stress, or mood disorders require medical attention when they become severe.
Pain and sensory perception
Cannabinoid receptors are located in areas involved in pain perception. This explains the scientific interest in cannabinoids in certain contexts. However, a general-interest article about CBD should not present cannabidiol as a pain reliever or treatment. This distinction is essential for maintaining credibility and compliance.
Sleep and biological rhythms
Sleep is a common concern when discussing CBD. The endocannabinoid system may play a role in certain balances related to rest, stress, and recovery. However, sleep quality depends on many factors: lifestyle, anxiety, screen time, diet, physical activity, circadian rhythm, and any existing medical conditions or treatments.
Appetite, metabolism and energy balance
Cannabinoids can interact with mechanisms related to appetite and metabolism. THC is known to influence appetite in some users. CBD, however, does not act in the same way and should not be presented as a solution for weight control or metabolism.
Immunity and inflammation
Because the CB2 receptor is associated with certain immune cells, the endocannabinoid system is studied in contexts related to immunity and inflammation. This does not allow us to conclude that a CBD product sold to the public can treat an inflammatory disease. A distinction must be made between basic research, clinical research, and commercial marketing.
How does CBD interact with the endocannabinoid system?
CBD does not act like THC. This is one of the most important points to understand. THC binds strongly to CB1 receptors, which explains its psychoactive effects. CBD, on the other hand, has a more indirect and complex behavior. It is being studied for its interactions with several signaling systems, including the endocannabinoid system, but also certain non-cannabinoid receptors.
INSERM indicates, in particular, that CBD does not bind to the same receptors as THC in the endocannabinoid system, and also mentions its interaction with the 5-HT1A serotonergic receptor, while noting that some effects remain to be demonstrated.
See INSERM's analysis on CBD.
An indirect action rather than a psychotropic effect
CBD is often described as a modulator. This means it can influence certain biological signals without causing the direct and strong activation of CB1 receptors associated with THC. This indirect action helps explain why CBD does not produce the same subjective effects as THC-rich cannabis.
CBD and other biological targets
CBD is also being studied for its interactions with other biological targets, including certain serotonin receptors, ion channels, and pathways related to sensory perception. This complexity explains why CBD research is active, but it also necessitates caution. The more systems a molecule interacts with, the more important it is to understand its effects, limitations, and potential interactions.
The World Health Organization has published a critical report on cannabidiol, often cited for its analysis of the safety profile of pure CBD.
Read the World Health Organization's report on cannabidiol.
Why does THC act differently from CBD?
THC acts differently because it has a high affinity for cannabinoid receptors, particularly CB1. This interaction explains its psychotropic effects. When THC activates CB1 in certain areas of the brain, it can alter perception, attention, coordination, short-term memory, and mood.
This distinction between CBD and THC is fundamental for consumer information. A compliant CBD product should not be equated with a product high in THC. Conversely, the presence of CBD in a product does not automatically neutralize the effects or risks of THC.
CBD, THC and regulatory confusion
The distinction between CBD and THC also has legal implications. CBD is permitted under certain conditions, particularly when products comply with the regulatory THC threshold and the rules applicable to their category. THC remains strictly regulated. This distinction must be emphasized in all serious content.
Related article:
CBD vs THC: differences, effects and legality.
What science knows, and what it doesn't yet know
The endocannabinoid system is well established as an important biological network, but not all of its mechanisms are fully understood. Research is progressing, but it remains complex. Results can vary depending on the models studied: cell studies, animal studies, clinical trials, epidemiological observations, or user feedback.
An introductory review published on PubMed describes the endocannabinoid system as a widely distributed neuromodulatory system involved in central nervous system development, synaptic plasticity, and responses to internal and environmental factors.
Read the scientific introduction to the endocannabinoid system on PubMed.
Why studies should not be overinterpreted
A scientific result does not automatically mean that a product available in stores can claim a specific benefit. It is important to distinguish between an observed biological mechanism, a research hypothesis, a validated medical indication, and a marketing claim. This distinction is essential for adhering to an EEAT (Expertise, Evaluation, Analysis, and Trust) approach and avoiding unauthorized claims.
CBD is not a mainstream medicine
The fact that CBD is being studied scientifically does not mean that all CBD products are medicines. A commercially sold product should not be presented as capable of treating, curing, or preventing any disease. In case of a health problem, a healthcare professional remains the appropriate person to consult.
Precautions: interactions, sensitive profiles, and responsible information
CBD should be approached with caution. While it doesn't produce the psychoactive effects of THC, it can interact with certain medications. People taking medication should seek medical advice before using any CBD product. This caution is especially important for medications metabolized by the liver.
Sensitive profiles
Pregnant or breastfeeding women, minors, people undergoing medical treatment, people with chronic illnesses, or those with particular vulnerabilities should avoid any trivialization of CBD. Responsible content should remind users of these limitations.
Driving and THC screening
Even when a CBD product is legal, it may contain traces of THC within the legal limit. THC can be detected during drug tests. Therefore, caution is necessary, especially before driving or engaging in any activity requiring heightened alertness.
Read:
CBD, driving and THC testing: what you need to know.
Responsible speech
An article on the endocannabinoid system should not turn biological complexity into a simplistic marketing ploy. The goal is to help the reader understand, not to promise a specific result. Careful wording, reliable sources, and clearly stated limitations enhance the credibility of a specialized website.
FAQ: Endocannabinoid system and CBD
Does the endocannabinoid system exist naturally in the body?
Yes. The endocannabinoid system is a natural biological system. It exists independently of any hemp or cannabis consumption. The body produces its own endocannabinoids.
Why is it called the endocannabinoid system?
It bears this name because it was discovered and studied in connection with cannabinoids. The prefix “endo” means “inside,” because endocannabinoids are produced by the body.
What are the main receptors of the endocannabinoid system?
The two best-known receptors are CB1 and CB2. CB1 is mainly present in the central nervous system, while CB2 is more associated with the immune system and peripheral tissues.
Does CBD activate receptors like THC?
No. CBD does not act like THC. THC strongly activates certain receptors, particularly CB1, which explains its psychotropic effects. CBD appears to have a more indirect and modulating action.
Does the endocannabinoid system explain all the effects of CBD?
No. CBD is being studied for several biological interactions, some of which extend beyond the strict endocannabinoid system. Its mechanisms remain complex and should not be reduced to a single explanation.
Can CBD replace medical treatment?
No. Commercially available CBD products should not replace medical treatment. In case of illness, persistent symptoms, or ongoing treatment, you should seek advice from a healthcare professional.
Why should we remain cautious about the promises surrounding CBD?
Because scientific research does not justify all commercial claims. A biological mechanism or a preliminary study does not always allow for a claim of a specific effect for a product sold to the public.
Does CBD get you high?
No. CBD does not produce the euphoric or psychotropic effects associated with THC. This difference is partly explained by its different mode of interaction with the endocannabinoid system.
Key points to remember about the endocannabinoid system
The endocannabinoid system is a natural biological network composed of endocannabinoids, receptors, and enzymes. It participates in several internal regulatory mechanisms and plays an important role in maintaining the body's balance. Its discovery has led to a better understanding of why plant cannabinoids like THC and CBD can interact with the human body.
CBD does not work like THC. It does not produce the psychoactive effects associated with THC-rich cannabis and appears to act more indirectly, by modulating several biological pathways. This difference is essential for a serious understanding of cannabidiol.
To remain reliable, content about CBD must always distinguish between scientific information, research hypotheses, wellness uses, and medical treatments. The endocannabinoid system is a fascinating subject, but it should not be used to promise guaranteed effects. A responsible approach relies on nuance, reliable sources, transparency, and caution.
Recommended next article:
CBD vs THC: effects, legal status and points to be aware of.
